Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-03-29
2011-03-29
Martinell, James (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
07914988
ABSTRACT:
The present invention provides a method for preparing a reference model for cancer relapse prediction that provides higher resolution grading than Gleason score alone. The method encompasses obtaining from different individuals a plurality of prostate carcinoma tissue samples of known clinical outcome representing different Gleason scores; selecting a set of signature genes having an expression pattern that correlates positively or negatively in a statistically significant manner with the Gleason scores; independently deriving a prediction score that correlates gene expression of each individual signature gene with Gleason score for each signature gene in said plurality of prostate carcinoma tissue samples; deriving a prostate cancer gene expression (GEX) score that correlates gene expression of said set of signature genes with the Gleason score based on the combination of independently derived prediction scores in the plurality of prostate cancer tissue samples; and correlating said GEX score with the clinical outcome for each prostate carcinoma tissue sample. A set of signature genes is provided that encompasses all or a sub-combination of GI_2094528, KIP2, NRG1, NBL1, Prostein, CCNE2, CDC6, FBP1, HOXC6, MKI67, MYBL2, PTTG1, RAMP, UBE2C, Wnt5A, MEMD, AZGP1, CCK, MLCK, PPAP2B, and PROK1. Also provided a methods for predicting the probability of relapse of cancer in an individual and methods for deriving a prostate cancer gene expression (GEX) score for a prostate carcinoma tissue sample obtained from an individual.
REFERENCES:
patent: 4469863 (1984-09-01), Ts'o et al.
patent: 5034506 (1991-07-01), Summerton et al.
patent: 5216141 (1993-06-01), Benner
patent: 5235033 (1993-08-01), Summerton et al.
patent: 5324633 (1994-06-01), Fodor et al.
patent: 5386023 (1995-01-01), Sanghvi et al.
patent: 5429807 (1995-07-01), Matson et al.
patent: 5436327 (1995-07-01), Southern et al.
patent: 5451683 (1995-09-01), Barrett et al.
patent: 5482867 (1996-01-01), Barrett et al.
patent: 5491074 (1996-02-01), Aldwin et al.
patent: 5561071 (1996-10-01), Hollenberg et al.
patent: 5583211 (1996-12-01), Coassin et al.
patent: 5602240 (1997-02-01), De Mesmaeker et al.
patent: 5624711 (1997-04-01), Sundberg et al.
patent: 5637684 (1997-06-01), Cook et al.
patent: 5644048 (1997-07-01), Yau
patent: 5658734 (1997-08-01), Brock et al.
patent: 5744305 (1998-04-01), Fodor et al.
patent: 5795716 (1998-08-01), Chee
patent: 5831070 (1998-11-01), Pease et al.
patent: 5837858 (1998-11-01), Brennan
patent: 5856101 (1999-01-01), Hubbell et al.
patent: 5858659 (1999-01-01), Sapolsky et al.
patent: 5874219 (1999-02-01), Rava et al.
patent: 5919523 (1999-07-01), Sundberg et al.
patent: 5968740 (1999-10-01), Fodor et al.
patent: 5974164 (1999-10-01), Chee
patent: 5981185 (1999-11-01), Matson et al.
patent: 5981956 (1999-11-01), Stern
patent: 6022963 (2000-02-01), McGall et al.
patent: 6025601 (2000-02-01), Trulson et al.
patent: 6033860 (2000-03-01), Lockhart et al.
patent: 6083697 (2000-07-01), Beecher et al.
patent: 6090555 (2000-07-01), Fiekowsky et al.
patent: 6136269 (2000-10-01), Winkler et al.
patent: 6200756 (2001-03-01), Herman et al.
patent: 6266459 (2001-07-01), Walt et al.
patent: 6287768 (2001-09-01), Chenchik et al.
patent: 6287776 (2001-09-01), Hefti
patent: 6288220 (2001-09-01), Kambara et al.
patent: 6291183 (2001-09-01), Pirrung et al.
patent: 6291193 (2001-09-01), Khodadoust
patent: 6297006 (2001-10-01), Drmanac et al.
patent: 6309831 (2001-10-01), Goldberg et al.
patent: 6355431 (2002-03-01), Chee et al.
patent: 6419949 (2002-07-01), Gasco
patent: 6428752 (2002-08-01), Montagu
patent: 6482591 (2002-11-01), Lockhart et al.
patent: 6489606 (2002-12-01), Kersey et al.
patent: 6514751 (2003-02-01), Johann et al.
patent: 6524793 (2003-02-01), Chandler et al.
patent: 6770441 (2004-08-01), Dickinson et al.
patent: 6859570 (2005-02-01), Walt et al.
patent: 6949342 (2005-09-01), Golub et al.
patent: 7106513 (2006-09-01), Moon et al.
patent: 7126755 (2006-10-01), Moon et al.
patent: 7164533 (2007-01-01), Moon et al.
patent: 7501248 (2009-03-01), Golub et al.
patent: 2002/0006617 (2002-01-01), Fan et al.
patent: 2002/0132241 (2002-09-01), Fan et al.
patent: 2003/0036064 (2003-02-01), Stuelpnagel et al.
patent: 2003/0108900 (2003-06-01), Oliphant et al.
patent: 2003/0170684 (2003-09-01), Fan
patent: 2003/0211489 (2003-11-01), Shen et al.
patent: 2003/0215821 (2003-11-01), Gunderson et al.
patent: 2003/0215827 (2003-11-01), Yue et al.
patent: 2004/0018491 (2004-01-01), Gunderson et al.
patent: 2004/0121364 (2004-06-01), Chee et al.
patent: 2004/0259105 (2004-12-01), Fan et al.
patent: 2005/0142573 (2005-06-01), Glinskii
patent: 2005/0181394 (2005-08-01), Steemers et al.
patent: 2005/0227252 (2005-10-01), Moon et al.
patent: 2005/0260664 (2005-11-01), Shaughnessy et al.
patent: 2006/0006327 (2006-01-01), Donaldson et al.
patent: 2006/0023310 (2006-02-01), Putnam et al.
patent: 2006/0071075 (2006-04-01), Moon et al.
patent: 2006/0119913 (2006-06-01), Moon
patent: 2006/0195266 (2006-08-01), Yeatman
patent: 2007/0099197 (2007-05-01), Afar et al.
patent: 2007/0220621 (2007-09-01), Clarke et al.
patent: WO 93/017126 (1993-09-01), None
patent: WO/95/35505 (1995-12-01), None
patent: WO 00/063437 (2000-10-01), None
patent: WO 2004/024328 (2004-03-01), None
patent: WO 2005/033681 (2005-04-01), None
Ausubel et al.,Current Protocols in Molecular Biology, John Wiley and Sons, Baltimore, MD, (2002) Cover and copyright page only.
Beaucage et al., “The Functionalization of Oligonucleotides Via Phosphoramidite Derivatives,”Tetrahedron49(10):1925 (1993).
Bettuzzi et al., “Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: a 5-year follow-up study,”Cancer Res. 63:3469-3472 (2003).
Bibikova et al., “Gene expression profiles in formalin-fixed, paraffin-embedded tissues obtained with a novel assay for microarray analysis,”Clin. Chem. 50:2384-2386 (2004).
Bibikova et al., “High-throughput DNA methylation profiling using universal bead arrays,”Genome Res. 16:383-393 (2006).
Bibikova et al., “Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays,”Am. J. Pathol. 165:1799-1807 (2004).
Brill et al., “Synthesis of of oligodeoxynucleoside phosphorodithioates via thioamidites”,J. Am. Chem. Soc., 111:2321-2322 (1989).
Butte, “The use and analysis of microarray data,”Nature Reviews Drug Discov. 1:951-960 (2002).
Carlsson et al., “Screening for genetic mutations,”Nature380:207 (1996).
De Mesmaeker et al., “Comparison of Rigid and Flexible Backbones in Antisense Oligonucleotides”,Bioorg. Medic. Chem. Lett., 4(3):395-398 (1994).
Dempcy et al., “Synthesis of a thymidyl pentamer of deoxyribonucleic guanidine and binding studies with DNA homopolynucleotides,”Proc. Natl. Acad. Sci. USA92:6097-6101 (1995).
Dhanasekaran et al., “Delineation of prognostic biomarkers in prostate cancer,”Nature412:822-826 (2001).
Egholm, “Oligonucleotide Analogues with an Achiral Peptide Backbone,”J. Am. Chem. Soc. 114:1895-1897 (1992).
Egholm, et al., “PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules,”Nature, 365:566 (1993).
Fan et al., “A versatile assay for high-throughput gene expression profiling on universal array matrices,”Genome Res. 14:878-885 (2004).
Fan et al., “Highly parallel SNP genotyping,”Cold Spring Harbor Symposia Quant. Biol. 68:69-78 (2003).
Febbo and Sellers et al., “Use of expression analysis to predict outcome after radical prostatectomy,”J. Urol. 170:S11-19, discussion S19-20 (2003).
Galinsky, “Automatic registration of microarray images. II. Hexagonal grid,”Bioinformatics19:1832-1836 (2003).
Glinsky et al., “Gene expression profiling predicts clinical outcome of prostate cancer,”J. Clin. Invest. 113:913-923 (2004).
Godfrey et al., “Quan
Bibikova Marina
Chudin Eugene
Fan Jian-Bing
Lozach Jean
Illumina, Inc.
Jones Day
Martinell James
LandOfFree
Gene expression profiles to predict relapse of prostate cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene expression profiles to predict relapse of prostate cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene expression profiles to predict relapse of prostate cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2674224